Your browser doesn't support javascript.
loading
Refining the mutational spectrum and gene-phenotype correlates in pontocerebellar hypoplasia: results of a multicentric study.
Nuovo, Sara; Micalizzi, Alessia; Romaniello, Romina; Arrigoni, Filippo; Ginevrino, Monia; Casella, Antonella; Serpieri, Valentina; D'Arrigo, Stefano; Briguglio, Marilena; Salerno, Grazia Gabriella; Rossato, Sara; Sartori, Stefano; Leuzzi, Vincenzo; Battini, Roberta; Ben-Zeev, Bruria; Graziano, Claudio; Mirabelli Badenier, Marisol; Brankovic, Vesna; Nardocci, Nardo; Spiegel, Ronen; Petkovic Ramadza, Danijela; Vento, Giovanni; Marti, Itxaso; Simonati, Alessandro; Dipresa, Savina; Freri, Elena; Mazza, Tommaso; Bassi, Maria Teresa; Bosco, Luca; Travaglini, Lorena; Zanni, Ginevra; Bertini, Enrico Silvio; Vanacore, Nicola; Borgatti, Renato; Valente, Enza Maria.
Afiliação
  • Nuovo S; Department of Human Neuroscience, Sapienza University of Rome, Roma, Italy.
  • Micalizzi A; Laboratory of Medical Genetics, IRCCS Bambino Gesù Children's Hospital, Roma, Italy.
  • Romaniello R; Neuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
  • Arrigoni F; Neuroimaging Lab, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
  • Ginevrino M; Laboratory of Medical Genetics, IRCCS Bambino Gesù Children's Hospital, Roma, Italy.
  • Casella A; Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.
  • Serpieri V; IRCCS Mondino Foundation, Pavia, Italy.
  • D'Arrigo S; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Briguglio M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Salerno GG; Department of Developmental Neurology, Fondazione IRCCS, Istituto Neurologico Carlo Besta, Milano, Italy.
  • Rossato S; Interdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
  • Sartori S; Child Neurology Unit, Department of Paediatrics, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Leuzzi V; U.O.C. Pediatria, Ospedale San Bortolo, Vicenza, Italy.
  • Battini R; Paediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.
  • Ben-Zeev B; Department of Human Neuroscience, Sapienza University of Rome, Roma, Italy.
  • Graziano C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Mirabelli Badenier M; Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
  • Brankovic V; Pediatric Neurology Department, The Edmond and Lilly Safra Pediatric Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Nardocci N; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Spiegel R; Medical Genetics Unit, AOU Policlinico di S. Orsola, Bologna, Italy.
  • Petkovic Ramadza D; Fondazione Istituto David Chiossone Onlus, Genova, Italy.
  • Vento G; Child Neuropsychiatry Unit, Department of Neurosciences and Rehabilitation, Istituto G. Gaslini, Genova, Italy.
  • Marti I; Clinic for Child Neurology and Psychiatry, University of Belgrade, Belgrade, Serbia.
  • Simonati A; Department of Child Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
  • Dipresa S; Department of Pediatrics B, Emek Medical Center, Afula, Israel.
  • Freri E; Rappaport School of Medicine, Technion, Haifa, Israel.
  • Mazza T; Department of Pediatrics, University Hospital Centre, Zagreb, Croatia.
  • Bassi MT; Division of Neonatology, Department of Woman and Child Health and Public Health, Child Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Roma, Italy.
  • Bosco L; Pediatric Neurology, Hospital Universitario Donostia, Biodonostia, Universidad del País Vasco UPV-EHU, San Sebastian, Spain.
  • Travaglini L; Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona School of Medicine and Department of Clinical Neuroscience AOUI Verona, Verona, Italy.
  • Zanni G; Department of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy.
  • Bertini ES; Department of Child Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
  • Vanacore N; Bioinformatics Unit, IRCCS Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Italy.
  • Borgatti R; Laboratory of Molecular Biology, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
  • Valente EM; Unit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience and Neurorehabilitation, IRCCS Bambino Gesù Children's Hospital, Roma, Italy.
J Med Genet ; 59(4): 399-409, 2022 04.
Article em En | MEDLINE | ID: mdl-34085948
ABSTRACT

BACKGROUND:

Pontocerebellar hypoplasias (PCH) comprise a group of genetically heterogeneous disorders characterised by concurrent hypoplasia of the pons and the cerebellum and variable clinical and imaging features. The current classification includes 13 subtypes, with ~20 known causative genes. Attempts have been made to delineate the phenotypic spectrum associated to specific PCH genes, yet clinical and neuroradiological features are not consistent across studies, making it difficult to define gene-specific outcomes.

METHODS:

We performed deep clinical and imaging phenotyping in 56 probands with a neuroradiological diagnosis of PCH, who underwent NGS-based panel sequencing of PCH genes and MLPA for CASK rearrangements. Next, we conducted a phenotype-based unsupervised hierarchical cluster analysis to investigate associations between genes and specific phenotypic clusters.

RESULTS:

A genetic diagnosis was obtained in 43 probands (77%). The most common causative gene was CASK, which accounted for nearly half cases (45%) and was mutated in females and occasionally in males. The European founder mutation p.Ala307Ser in TSEN54 and pathogenic variants in EXOSC3 accounted for 18% and 9% of cases, respectively. VLDLR, TOE1 and RARS2 were mutated in single patients. We were able to confirm only few previously reported associations, including jitteriness and clonus with TSEN54 and lower motor neuron signs with EXOSC3. When considering multiple features simultaneously, a clear association with a phenotypic cluster only emerged for EXOSC3.

CONCLUSION:

CASK represents the major PCH causative gene in Italy. Phenotypic variability associated with the most common genetic causes of PCH is wider than previously thought, with marked overlap between CASK and TSEN54-associated disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atrofias Olivopontocerebelares / Doenças Cerebelares Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Med Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atrofias Olivopontocerebelares / Doenças Cerebelares Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Med Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália